Bridge Medicines - Crunchbase Company Profile & Funding

Q: Who invested in Bridge Medicines?

Bridge Medicines has 3 investors including Takeda And Bay City Capital.

Q: When was the last funding round for Bridge Medicines?

Bridge Medicines closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Bridge Medicines raised to date?

Bridge Medicines has raised obfuscated.

Overview

Bridge Medicines

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Bridge Medicines

CB Rank

106391

Bridge Medicines is a drug discovery company

Founded

obfuscation

Private

Venture - Series Unknown

Sioux Falls, South Dakota, United States

11-50

bridgemedicines.com/

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

William J. Polvino: CEO & Director
Louis M. Renzetti: CSO

Details

Legal Name

Bridge Medicines

Operating Status

Active

Company Type

For Profit

About the Company

Bridge Medicines is a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Bridge Medicines is a groundbreaking initiative that completes an

unbroken, fully funded and professionally staffed path from concept to drug candidate, to develop efficiently and quickly innovative therapeutics for the treatment of human diseases.

Predictions & Insights

Growth Insight

See this Growth Insight

Bridge Medicines is

Lorem

to be growing

Top Contributing Factors

Operations Contraction

Growth Prediction

See this Growth Prediction

Products & Services

UBR5 Inhibitor Program

A drug development program focused on small molecule inhibitors targeting UBR5 to treat resistant cancers.

Small Molecule Inhibitors of Activated Factor XII

Development of small molecule inhibitors targeting activated Factor XII for therapeutic applications.

Research & Development

Bridge Medicines is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Bridge Medicines	3	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Takeda	—	Venture Round - Bridge Medicines	—
Takeda	—	Venture Round - Bridge Medicines	—
Takeda	—	Venture Round - Bridge Medicines	—
Takeda	—	Venture Round - Bridge Medicines	—
Takeda	—	Venture Round - Bridge Medicines	—